On this page
Dalfampridine
Active ingredient 3 prescription 3 with labelling
Overview
Source: NDC DirectoryIngredient name
DALFAMPRIDINE
Base moiety
DALFAMPRIDINE
RxNorm CUI
UNII
BH3B64OKL9
Medication products
6
Brand names
3
Dosage forms
3
FAERS reports
71,317 · not a risk measure
- 4-Aminopyridine Powder
- Dalfampridine Powder
- DALFAMPRIDINE MICRONIZED Dalfampridine Micronized · Powder
- AMPYRA Dalfampridine · Tablet, Film Coated, Extended Release
- Dalfampridine Tablet, Film Coated, Extended Release
- DALFAMPRIDINE Dalfampridine · Tablet, Extended Release
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Powder | 3 | 4-Aminopyridine, Dalfampridine, DALFAMPRIDINE MICRONIZED |
| TABLET, Film COATED, Extended Release | 2 | AMPYRA, Dalfampridine |
| TABLET, Extended Release | 1 | DALFAMPRIDINE |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |